Citation Impact
Citing Papers
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
2015
Breast cancer
2019 Standout
Breast imaging technology: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer
2000
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
2008
Molecular imaging in drug development
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
PET as a potential tool for imaging molecular mechanisms of oncology in man
2001
The use of scintigraphic imaging as a tool in the development of liposome formulations
2001
Monitoring chemotherapy and radiotherapy of solid tumors
2006
Super-SILAC mix for quantitative proteomics of human tumor tissue
2010
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?
2003
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
2003
Imaging in the era of molecular oncology
2008 StandoutNature
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1
2004
Using imaging biomarkers to accelerate drug development and clinical trials
2005
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
Synthesis and In Vivo Imaging of a 18F‐Labeled PARP1 Inhibitor Using a Chemically Orthogonal Scavenger‐Assisted High‐Performance Method
2011
Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphoma
2001
18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
2009
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Nasopharyngeal carcinoma
2019 Standout
Esophageal Cancer
2003 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
2014
Unexpected evidence for active brown adipose tissue in adult humans
2007 Standout
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma
2008
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Assessing responses to cancer therapy using molecular imaging
2006
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
2016
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
The Perseus computational platform for comprehensive analysis of (prote)omics data
2016 Standout
Regulation of cancer cell metabolism
2011 Standout
Cancer metabolism: facts, fantasy, and fiction
2003
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study
2004
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Functional regulation of HIF‐1α under normoxia—is there more than post‐translational regulation?
2011
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
New approaches for imaging tumour responses to treatment
2008
Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography
2001
Targeting aspartate aminotransferase in breast cancer
2008
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET
2002
Optical properties of biological tissues: a review
2013 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas
2008
Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis
2005
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
2008
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
2004
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future
2011
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial
2004
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Increased susceptibility of HIF-1α heterozygous-null mice to cardiovascular malformations associated with maternal diabetes
2013 StandoutNobel
Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG
2007
Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods
2003
Mitochondria and cancer
2012 Standout
Terahertz Pulsed Imaging of Human Breast Tumors
2006 Standout
Use of proteomic patterns in serum to identify ovarian cancer
2002 Standout
The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
2007
Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer Prediction
2001
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
2011
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Positron Emission Tomography Scanning: Current and Future Applications
2002
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Powerful Prognostic Stratification By [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy
2006
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Use of PET for monitoring cancer therapy and for predicting outcome.
2005
Fundamentals of cancer metabolism
2016 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
2007
Prospective Multicenter Study of Axillary Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of the Staging Breast Cancer With PET Study Group
2004
False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases
2006
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography
2005
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
2005
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.
2004
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
2003
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
18F-FDG PET/CT Imaging In Oncology
2011
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Fluorine in medicinal chemistry: A review of anti-cancer agents
2006
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
2001
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
2003
FDG-PET and Beyond: Molecular Breast Cancer Imaging
2005
Primary Systemic Therapy of Breast Cancer
2006
Works of M. Schelling being referenced
Combined Transvaginal B-Mode and Color Doppler Sonography for Differential Diagnosis of Ovarian Tumors: Results of a Multivariate Logistic Regression Analysis
2000
Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
2000
Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
2000
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
2001